Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editors and Section Editors for this issue.
Linda S. Sher
Dr Sher is Associate Professor of Clinical Surgery and Director of Clinical Research in the Division of Hepatobiliary Surgery and Abdominal Organ Transplantation at Keck School of Medicine, University of Southern California (USC), USA. After completing her medical school education and surgical residency at Mount Sinai School of Medicine in New York, USA, Dr Sher undertook her fellowship training in Liver and Kidney Transplantation at the University of Pittsburgh, USA. After completing her fellowship in 1988, Dr Sher was involved in the establishment of two liver transplant programs in Los Angeles prior to joining the USC program in 2001. Dr Sher has participated in and overseen over 50 research projects and is currently very active in the development of the clinical and basic science research components of the USC Abdominal Organ Transplantation Program. She has numerous publications on immunosuppression, chronic rejection, disease recurrence, infection, prophylaxis and hepatobiliary surgery.
Dr Sher is one of the original editors of Current Opinion in Organ Transplantation and has endeavored over the years to provide the reader with an up to date overview of the entire field of organ transplantation.
Donald V. Cramer
Dr Cramer is a former professor of research for the Departments of Cardiothoracic Surgery and Molecular Microbiology and Immunology, and the Director of Research of the Department of Cardiothoracic Surgery at the Keck School of Medicine, University of South Carolina, USA. He earned his Doctor of Veterinary Medicine from the University of California, UC Davis, USA and a Ph.D. in Experimental Pathology at Harvard University, USA.
From 1971 to 1989, Dr Cramer served as a member of the tenured faculty with the Department of Pathology, University of Pittsburgh School of Medicine, USA. Between 1989 and 1995, he served as director of transplantation biology at Cedars-Sinai Medical Center, and at St. Vincent Medical Center from 1995 to 1998. Dr Cramer then served in the Department of Cardiothoracic Surgery as director of cardiothoracic research from 1998 to 2003.
Dr Cramer has a long-term interest in research in immunology, genetics, and transplantation biology. His recent research activities focus on preventing the host immune responses to foreign tissue grafts as part of a program to develop alternative sources of donor tissues for patients awaiting organ transplants. His research efforts are aimed at understanding the nature of the host immune responses and developing methods to prevent graft rejection. Dr Cramer currently serves as an Independent Scientific Advisor to academic research units and several small biotechnology firms.
Josep M. Grinyo
Professor Grinyo' was born in Corbins, Spain, and began his medical studies at the University of Barcelona, Spain in 1973. He became a specialist in nephrology at the University of Barcelona in 1979, and obtained his PhD in 1981.
Professor Grinyo' has been chief of the Renal Transplant Unit at the University Hospital of Bellvitge, Spain since 1988, and in 1992 he became full Professor of Medicine at the University of Barcelona. His main fields of research are immunosuppression, ischemia reperfusion injury, and chronic allograft damage. Since 1990, Professor Grinyo' has taken part in over 80 invited lectures and published more than 100 communications and articles.
He is the Associate Editor of Current Opinion in Organ Transplantation, the Journal of Nephrology, the American Journal of Transplantation and Nephrology Dialysis and Transplantation, and is a member of the Council of the European Society for Organ Transplantation.
Barbara Wasowska is originally from Poland. She received her PhD in Immunology at the Polish Academy of Sciences in Warsaw, Poland in 1981. She did her initial postgraduate training at the Transplantation Laboratory in Helsinki, Finnish Academy of Sciences and at the Department of Clinical Immunology, University of Goeteborg Sohlgren's Hospital, Swedish Academy of Sciences. In 1989 she joined the Transplant Research Laboratory at Duke University Medical Center in Durham, USA and then in 1992, Transplant Research Laboratories at the Beth Israel and Brigham and Women's Hospitals, Harvard Medical School in Boston, USA, where she completed her postdoctoral fellowships. In 1996 she obtained a junior faculty position at the Johns Hopkins University (JHU) School of Medicine in Baltimore, USA, and became an Assistant Professor of Immunopathology in 2000. Besides research Dr Wasowska is actively involved in giving lectures on immunology and organ transplantation in the JHU Pathobiology Graduate Program.
Dr Wasowska is an internationally recognized expert in transplant immunology. Her research interests have been focused on studying the mechanisms of antibody-, complement- and cytokine-mediated endothelial cell injury; the role of glycosylation patterns of antibodies in expression of pro- or anti-inflammatory functions and in regulation of complement- and FcγR-dependent pathways that link innate and adaptive immune responses in allograft rejection.
Dr Wasowska is an active member of several professional societies, including the World Transplantation Society and the American Society of Transplantation. She serves as a reviewer for the American Journal of Transplantation, Transplantation, Immunobiology and The Open Surgery Journal. She has published around 100 peer-reviewed papers and book chapters. Her research for the last 15 years has been continuously funded by the National Institute of Health, American Heart Association, Roche Organ Transplant Research Foundation and other extramural grants.
Dr Kearns-Jonker obtained her graduate training in transplantation biology at McGill University, USA. She completed two postdoctoral fellowships at the National Institutes of Health prior to accepting a position as a research scientist at Cedars Sinai Medical Center in California, USA. In 1995, she moved to St. Vincent Medical Center and remained there for three years prior to accepting a position as an Assistant Professor in Cardiothoracic Surgery at the University of Southern California Keck School of Medicine, USA. She remained an active member of the faculty at USC with her laboratory located at Children's Hospital Los Angeles in the Cardiovascular Program with additional appointments in the Gene, Immune, Stem Cell Therapy and Developmental Biology and Regenerative Medicine Programs for twelve years. During this time, she served as both Chair of the Institutional Biosafety Committee of Children's Hospital Los Angeles and as a member of the IACUC Committee at Children's Hospital, and was actively involved in the training of postdoctoral fellows and graduate students. In 2010, she accepted a position as an Associate Professor at Loma Linda University School of Medicine, USA in the Dept. of Pathology and Human Anatomy. Dr Kearns-Jonker has numerous publications, invited presentations, and book chapters and is an editor of two books. Her laboratory is funded by both the NIH and CIRM, and her research is focused in the areas of transplantation immunology and the use of stem cells for myocardial repair in small and large animal models.
Jose Figueiro, MD is an Assistant Professor of Surgery (Transplantation) at Weill Cornell Medical College, USA and an Assistant Attending Surgeon at New York Presbyterian-Weill Cornell Medical Center, USA.
He received his Medical Degree from Federal University School of Medicine, Brazil, in 1993. After completing his general surgery program, he completed a clinical fellowship at Centre Hepato-Biliaire, Hopital Paul Brousse, Paris, France, under the supervision of Henri Bismuth; and completed an Abdominal Organ Transplantation Fellowship at Jackson Memorial Hospital / University of Miami, USA in 2000.
From 2001 to 2007 Dr Figueiro played a leadership role in the development of transplant activities in Brazil, as well as throughout South America, pioneering pancreas transplantation in his region, creating local awareness of expanded criteria donors for kidney/pancreas transplant; and developing novel immune medication protocols. His clinical expertise focused on kidney and pancreas transplantation and hepatobiliary surgery, performing over a 1000 kidney and 400 pancreas transplants during these years in Brazil.
Dr Figueiro is an active member of several transplantation societies in Latin America, previously served the Brazilian Government Pancreas Transplant committee and played a strong leadership role in surgical education. He has been recruited to Weill Cornell Medical College to focus on developing and expanding the pancreas transplantation program.
© 2011 Lippincott Williams & Wilkins, Inc.